Aptamers in Osteosarcoma: New Paths for Diagnosis and Treatment
Aptamers represent a promising class of targeted agents for osteosarcoma. Future research should prioritize optimizing delivery strategies and validating clinical efficacy to accelerate their integration into clinical practice.
Authors
- Antoine Chartouni (ORCID: https://orcid.org/0000-0002-8140-8520)
- Marc Boutros
- Juan Pretell-Mazzini
- Guy Awad
Institutions
- Baptist Hospital of Miami (US)
- Saint Joseph University (LB)
- Baptist Health South Florida (US)
Publication Details
- Journal
- Anti-Cancer Agents in Medicinal Chemistry
- Published
- 2026-03-04
- DOI
- https://doi.org/10.2174/0118715206398665251010093110
- Primary Topic
- Advanced biosensing and bioanalysis techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00